Zelluna ASA (OSL:ZLNA)
Norway · Delayed Price · Currency is NOK 22.00
+0.40 (1.85%)
Jun 4, 2026, 9:29 AM CET
Zelluna ASA Revenue
Zelluna ASA had revenue of 8.00K NOK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 8.00K, down -84.91% year-over-year.
Revenue (ttm)
8.00K
Revenue Growth
-84.91%
P/S Ratio
70,928.46
Revenue / Employee
533.33
Employees
24
Market Cap
567.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 53.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 13.30M | 175.00K | 1.33% |
| Dec 31, 2021 | 13.13M | 704.38K | 5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 128.37M |
| Arctic Bioscience AS | 42.62M |
| Oncoinvent ASA | 28.07M |
| SoftOx Solutions AS | 15.58M |
| Aqua Bio Technology ASA | 7.53M |
| Nykode Therapeutics AS | 5.42M |
| Thor Medical ASA | 839.00K |
| Lytix Biopharma ASA | 377.00K |
Zelluna ASA News
- 4 weeks ago - Zelluna ASA Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - Zelluna ASA Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Zelluna ASA Slides: Q1 2026 - Filings
- 7 weeks ago - Zelluna ASA Transcript: Capital Markets Update 2026 - Transcripts
- 7 weeks ago - Zelluna ASA Slides: FY 2026 - Filings
- 3 months ago - Q4 2025 Zelluna ASA Earnings Presentation Transcript - GuruFocus
- 4 months ago - Zelluna ASA Earnings Call Transcript: Q4 2025 - Transcripts
- 4 months ago - Zelluna ASA Annual report: Q4 2025 - Filings